Adir Et Compagnie

Les Laboratoires Servier

Les Laboratories Servier

Les Laboratories Server

Centre National De La Recherche Scientifique

L'institut National Des Sciences Appliquées De Rouen

L'universite De Rouen

Alain Rupin

Tony Verbeuren

Guillaume De Nanteuil

Philippe Gloanec

Marie-Odile Vallez

Serge Simonet

Christine Lila

Patricia Sansilvestri-Morel

Bernard Portevin

Jean-Gilles Parmentier

Philippe Mennecier

Michel Laubie

Michel Wierzbicki

François Lefoulon

Alain Benoist

Jérôme Paysant

Arnaud-Pierre Schaffner

Christophe Thurieau

Anne-Françoise Guillouzic

Jean-Luc Fauchere

Jean-Charles Quirion

Marie-Francoise Boussard

Christine Courchay

Marie-Françoise Boussard

Philippe Jubault

Nicolas Boyer

Guillaume De Manteuil

Jerome Paysant

Francois Lefoulon

Marie Françoise Boussard

Compounds of formula (I) wherein: Medicinal products containing the same which are useful in treating conditions requiring a TAFIa inhibitor.

Compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them

Compounds of formula (I) wherein:Akrepresents an alkyl chain,X represents &#x2014;(CH)&#x2014;, &#x2014;CH(R)&#x2014;, &#x2014;N(R)&#x2014;, &#x2014;CH&#x2014;N(R)&#x2014;, &#x2014;N(R)&#x2014;CH&#x2014; or &#x2014;CH&#x2014;N(R)&#x2014;CH&#x2014;, Medicinal products containing the same which are useful in treating conditions requiring a TAFIa inhibitor.

Compounds of formula (I): wherein R, Rand R, which may be the same or different, each represent a hydrogen atom or the group of formula (A):  Medicinal products containing the same which are useful in the prevention and/or treatment of venous diseases and other conditions.

Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them

Compounds of formula (I): wherein:  Medicinal products containing the same which are useful in treating and/or preventing thrombotic events.

2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them

Compounds of formula (I): wherein R, Rand R, which may be the same or different, each represent a hydrogen atom or the group of formula (A): Medicinal products containing the same which are useful in the prevention and/or treatment of venous diseases and other conditions.

Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them

Compounds of formula (I):(A)&#xb7;(B)&#x2003;&#x2003;(I)wherein A represents an angiotensin-converting enzyme inhibitor compound containing at least one salt-forming basic function, B represents a compound containing at least one salt-forming acid function and at least one NO donor group, m represents the number of acid functions of B that have been converted to a salt and n represents the number of basic functions of A that have been converted to a salt,the bond or bonds between A and B being of the ionic type. Medicinal products containing the same which are useful in treating cardiovascular pathologies.

Addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them

Compound of formula (I): wherein: represents 1-oxidopyridyl substituted by the remainder of the molecule in any one of the positions 2, 3 and 4, Medicinal products containing the same which are useful as thrombin inhibitors.

4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds

Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative

Bicyclic amino-pyrazinone compounds

A compound selected from those of formula (I):

Benzothiophene, benzofuran and indole compounds

2,3-methano-amino acid compounds

A compound of formula (I): ##STR1## wherein: X represents oxygen, sulphur, or NR.sub.3 wherein R.sub.3 is as defined in the description,

Compound of formula (I) ##STR1## in which: R.sub.1 and R.sub.2, which are identical or different, represent hydrogen or alkyl or alternatively R.sub.1 and R.sub.2 form, with the carbon atom which bears them, cycloalkyl,

Compounds derived from boronic acid

Peptide compounds which are therapeutically active in the cascade of

Growing community of inventors

Savonnieres, France

Alain Rupin